These proteins are overexpressed in several cancers and are associated with poor prognosis and aggressive tumour growth; therefore, targeting 14-3-3 proteins could be a new strategy by which ebselen 4 makes cancer cells more susceptible to chemotherapy treatment, thus overcoming drug resistance. The gene discussed is YWHAQ; the disease is cancer.